The KOOL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the KOOL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The KOOL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View KOOL Detailed Price Forecast - CNN Money||View KOOL Detailed Summary - Google Finance|
|View KOOL Detailed Summary - Yahoo! Finance||View KOOL Stock Research & Analysis - Zacks.com|
|View KOOL Trends & Analysis - Trade-Ideas||View KOOL Major Holders - Barrons|
|View KOOL Call Transcripts - NASDAQ||View KOOL Breaking News & Analysis - Seeking Alpha|
|View KOOL Annual Report - CompanySpotlight.com||View KOOL OTC Short Report - OTCShortReport.com|
|View KOOL Fundamentals - TradeKing||View KOOL SEC Filings - Bar Chart|
|View Historical Prices for KOOL - The WSJ||View Performance/Total Return for KOOL - Morningstar|
|View the Analyst Estimates for KOOL - MarketWatch||View the Earnings History for KOOL - CNBC|
|View the KOOL Earnings - StockMarketWatch||View KOOL Buy or Sell Recommendations - MacroAxis|
|View the KOOL Bullish Patterns - American Bulls||View KOOL Short Pain Metrics - ShortPainBot.com|
|View KOOL Stock Mentions - StockTwits||View KOOL Stock Mentions - PennyStockTweets|
|View KOOL Stock Mentions - Twitter||View KOOL Investment Forum News - Investor Hub|
|View KOOL Stock Mentions - Yahoo! Message Board||View KOOL Stock Mentions - Seeking Alpha|
|View Insider Transactions for KOOL - SECform4.com||View Insider Transactions for KOOL - Insider Cow|
|View KOOL Major Holdings Summary - CNBC||View Insider Disclosure for KOOL - OTC Markets|
|View Insider Transactions for KOOL - Yahoo! Finance||View Institutional Holdings for KOOL - NASDAQ|
|View KOOL Stock Insight & Charts - FinViz.com||View KOOL Investment Charts - StockCharts.com|
|View KOOL Stock Overview & Charts - BarChart||View KOOL User Generated Charts - Trading View|
Cesca Therapeutics Announces Exhibition at The Orthobiologic Institute’s 9th Annual PRP & Regenerative Medicine Symposium
Posted on Wednesday June 06, 2018
Cesca Therapeutics Inc. (“Cesca” or the “Company”) (KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will be exhibiting its development-stage PXP™ System at The Orthobiologic Institute’s (TOBI) 9th Annual PRP & Regenerative Medicine Symposium with Workshops & Cadaver Labs, which is being held June 7-9 in Las Vegas. “In a mini review recently published in the peer-reviewed Journal of Orthopedic Research and Therapy, we report on the role of various bone marrow derived cells and cytokines used in the treatment of different orthopedic indications, such as knee osteoarthritis,” said Dalip Sethi, Ph.D., Senior Director of Research and Development at Cesca.
Rancho Cordova-based Cesca Therapeutics cutting about 20 jobs
Posted on Monday June 04, 2018
Rancho Cordova-based medical technology company Cesca Therapeutics Inc. said it's cutting 25 percent of its workforce to reduce expenses.
Cesca Therapeutics Announces Reduction in Operating Expenses
Posted on Monday June 04, 2018
Cesca Therapeutics Inc. (“Cesca” or the “Company”) (KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it is reducing its US and India workforce by approximately 25%, to a total of 60 full-time equivalent employees, under a plan to be substantially completed by the end of June. This reduction is designed to lower operating expenses while the Company focuses on driving growth of revenue-generating products, while at the same time continuing to develop and commercialize the CAR-TXpress™ cellular processing platform and related X-Series™ products. “Focusing our efforts on the development and commercialization of CAR-TXpress, and increasing sales of our revenue-generating products, will best position the Company for long-term success,” said Chris Xu, chief executive officer of Cesca.
Cesca Therapeutics Inc’s (NASDAQ:KOOL) Profit Outlook
Posted on Thursday May 31, 2018
Cesca Therapeutics Inc’s (NASDAQ:KOOL): Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe,Read More...